Industry News • December 05, 2019
New York, NY, December 4, 2019 – NMS Capital (“NMS”) announced today that it has partnered with company management in the recapitalization of Center for Social Dynamics, Inc. (“CSD” or the “Company”). CSD is a leading applied behavioral analysis (“ABA”) services company specializing in home-based, personalized, evidence-based Autism Spectrum Disorder (“ASD”) treatment. In connection with the transaction, NMS has made a substantial capital commitment to support the growth of CSD.
Founded in 2012, CSD provides ABA services throughout Northern California, Oregon, and Hawaii to over 1,200 clients, primarily under the age of 15, with its clinical staff of over 600. Since founding, CSD has worked to build an organization driven by and focused on clinical excellence and high-quality outcomes, leveraging management’s extensive experience in behavioral health and autism services. CSD maintains extensive and long-standing relationships with key commercial insurers throughout its core geographies, affording the Company numerous avenues for growth. In connection with the transaction, Founder and CEO Pete Pallares will continue in his leadership role and retain a significant ownership stake in CSD.
“This partnership with NMS represents a major step in facilitating CSD’s next phase of growth,” said Mr. Pallares. “NMS’ track record and experience investing in the healthcare arena make them the right partner for CSD, and I am excited to continue the growth of our platform together. This outside capital will allow CSD to accelerate its growth plan in both new and existing geographies, while maintaining the high clinical and client standards to which we have always held ourselves.”
Martin Chavez, NMS Co-Founder and Managing Partner remarked, “Pete has done an outstanding job establishing and growing the CSD platform, and NMS is proud to partner with him and the rest of the Company’s management team. Our investment in CSD is a continuation of NMS’ theme-based approach to identifying differentiated opportunities in targeted sectors through extensive research and thesis development, and extensive evaluation of select management teams in our target industries. NMS evaluated a number of ABA and ASD services companies and believes that CSD represents a leading platform with an outstanding clinical and client-care model.”
David Peterson, NMS Managing Director added, “We are incredibly excited to partner with CSD, a leading platform with a commitment to clinical quality and client outcomes. Pete’s vision for CSD is tremendous and we look forward to leveraging our past experiences and resources to support him and the CSD team in the years to come as we build a premier autism therapy provider.”
The NMS deal team also included Neal Monga and Colin Durney. McDermott Will & Emery provided legal advice to NMS. Huron Transaction Advisory LLC served as financial advisor to CSD, and Sheppard Mullin provided legal advice to CSD.
This article originally appeared in an article in PEHub.